Protara Therapeutics, Inc. (TARA) earnings
TARA earnings moved a median of -1.46% by the close. Quarterly and annual TARA reports and results, each read against the price at its own news timestamp. Back to the TARA overview →
21 measured TARA earnings events.
Where these TARA earnings landedvs 21 measured TARA earnings reactions
| Middle 50% of TARA earnings reactions | -2.25% to +2.79% |
|---|---|
| Median reaction (to close) | -1.46% |
| Measured reactions | 21 |
Point-in-time · zero look-ahead
Half of the 21 TARA earnings events with a measured close landed between -2.25% and +2.79%; 33% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Protara Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.25% | -2.25% | |
| Protara Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update | Press release | -1.25% | -2.25% | |
| Form 10-Q Protara Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -3.77% | -1.89% | |
| Protara Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update | Press release | -3.77% | -1.89% | |
| Form 10-K Protara Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -2.73% | |
| Form 10-Q Protara Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.82% | +5.84% | |
| Protara Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update | Press release | +0.82% | +5.84% | |
| Form 10-Q Protara Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -1.28% | -0.96% | |
| Protara Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update | Press release | -1.28% | -0.96% | |
| Form 10-Q Protara Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.02% | -1.46% | |
| Protara Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update | Press release | +1.02% | -1.46% | |
| Form 10-K Protara Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.08% | +8.04% | |
| Form 10-Q Protara Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +2.79% | |
| Protara Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update | Press release | +0.00% | +2.79% | |
| Form 10-Q Protara Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.36% | |
| Protara Therapeutics Announces Second Quarter 2024 Financial Results and Provides a Business Update | Press release | +0.00% | -2.36% | |
| Form 10-Q Protara Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.17% | -2.37% | |
| Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update | Press release | -0.17% | -2.37% | |
| Form 10-K Protara Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.43% | -1.35% | |
| Form 10-Q Protara Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +2.90% | +8.87% | |
| Protara Therapeutics Announces Third Quarter 2023 Financial Results and Business Update | Press release | +2.90% | +8.87% |
Keep exploring
More TARA: analyst actions → · SEC filings → · TARA overview →